Tamiflu effects 'still uncertain'

 

The effects of antiviral drug Tamiflu - which was stockpiled by the Government at the height of the swine flu pandemic - are still uncertain, researchers said as they accused pharmaceutical giant Roche of withholding data.

A 2009 study in the British Medical Journal (BMJ) found the drug may cut the length of time people have symptoms but found no clear evidence that it prevented complications like pneumonia.

Experts from the Cochrane Collaboration conducted a review of 20 existing studies.

They found Tamiflu "did not reduce influenza-related lower respiratory tract complications" but did induce nausea.

Evidence of other adverse reactions to the drug were "possibly under-reported", they said.

The study criticised the evidence available from Roche and said the firm had not been able "unconditionally" to provide the information needed for the study.

At the height of the swine flu pandemic, the UK Government had contracts in place for 50 million doses of Tamiflu - enough for 80% of the population.

Tamiflu is still available for use when flu is circulating at high levels.

Today, a new report from the Cochrane Collaboration said the question of how well Tamiflu works remains unresolved owing to Roche's continued refusal to provide full access to its data.

Following the 2009 study, Roche did provide 3,195 pages of study reports for 10 treatment trials of Tamiflu but these were incomplete, the experts said.

"We cannot be certain whether the trial evidence supports the conclusion that (Tamiflu) reduces complications," they added.

"Nor do we understand if and how (Tamiflu) changes immune response, and important questions about its mode of action remain.

"But we think a critical analysis of the full clinical study reports - comprising tens of thousands of pages we have not yet seen - may provide critical answers."

The team added that "open access to all relevant trial data is a necessity to make ethical decisions in healthcare".

Dr Fiona Godlee, editor-in-chief of the BMJ, which ran an accompanying investigation about access to drug data, said "we are still a long way away from having a full trial history for all drugs in clinical use".

"Public safety and the proper use of public money demands that we should stop at nothing less than this."

Dr Peter Doshi from Johns Hopkins University School of Medicine, who worked on the new study, added: "In the BMJ in December 2009, Roche promised full study reports to any legitimate investigators.

"They have not provided a single full study report to Cochrane, despite our repeated requests."

A statement from Roche said: "Roche has made full clinical study data available to health authorities around the world for their review as part of the licensing process.

"It is the role of global health authorities to review detailed information on medicines when assessing benefit/risk.

"All completed Roche-sponsored clinical studies on the safety and efficacy of Tamiflu are available as peer-reviewed publications or in summary form on www.roche-trials.com.

"More detailed clinical trial reports are available for use by investigators on a password-protected site, enabling researchers to verify the findings of these studies and publications relating to them.

"Roche provided the Cochrane group with access to 3,200 pages of very detailed information, enabling their questions to be answered.

"Roche stands behind the robustness and integrity of our data supporting the efficacy and safety of Tamiflu."

A spokeswoman for the Department of Health said: "At the end of last year we published a major review of the scientific evidence base, which showed a clear benefit in offering antivirals to those with severe illness and those with additional risk factors."

PA

Life and Style
ebookNow available in paperback
ebooks
ebookPart of The Independent’s new eBook series The Great Composers
  • Get to the point
Latest stories from i100
Have you tried new the Independent Digital Edition apps?

ES Rentals

    Independent Dating
    and  

    By clicking 'Search' you
    are agreeing to our
    Terms of Use.

    iJobs Job Widget
    iJobs General

    Ashdown Group: Front-End UI Application Developer

    £30000 - £40000 per annum + Benefits: Ashdown Group: Front-End UI Application ...

    Recruitment Genius: Digital Account Executive

    £18000 - £26000 per annum: Recruitment Genius: They work with major vehicle ma...

    Recruitment Genius: Service Engineers - Doncaster / Hull

    £27000 per annum: Recruitment Genius: Domestic Service Only Engineers are requ...

    Recruitment Genius: Employability / Recruitment Adviser

    £23600 - £27500 per annum: Recruitment Genius: The Employability Service withi...

    Day In a Page

    Where the spooks get their coffee fix: The busiest Starbucks in the US is also the most secretive

    The secret CIA Starbucks

    The coffee shop is deep inside the agency's forested Virginia compound
    Revealed: How the Establishment closed ranks over fallout from Loch Ness Monster 'sighting'

    How the Establishment closed ranks over fallout from Nessie 'sighting'

    The Natural History Museum's chief scientist was dismissed for declaring he had found the monster
    One million Britons using food banks, according to Trussell Trust

    One million Britons using food banks

    Huge surge in number of families dependent on emergency food aid
    Excavation at Italian cafe to fix rising damp unearths 2,500 years of history in 3,000 amazing objects

    2,500 years of history in 3,000 amazing objects

    Excavation at Italian cafe to fix rising damp unearths trove
    The Hubble Space Telescope's amazing journey, 25 years on

    The Hubble Space Telescope's amazing journey 25 years on

    The space telescope was seen as a costly flop on its first release
    Did Conservative peer Lord Ashcroft quit the House of Lords to become a non-dom?

    Did Lord Ashcroft quit the House of Lords to become a non-dom?

    A document seen by The Independent shows that a week after he resigned from the Lords he sold 350,000 shares in an American company - netting him $11.2m
    Apple's ethnic emojis are being used to make racist comments on social media

    Ethnic emojis used in racist comments

    They were intended to promote harmony, but have achieved the opposite
    Sir Kenneth Branagh interview: 'My bones are in the theatre'

    Sir Kenneth Branagh: 'My bones are in the theatre'

    The actor-turned-director’s new company will stage five plays from October – including works by Shakespeare and John Osborne
    The sloth is now the face (and furry body) of three big advertising campaigns

    The sloth is the face of three ad campaigns

    Priya Elan discovers why slow and sleepy wins the race for brands in need of a new image
    How to run a restaurant: As two newbies discovered, there's more to it than good food

    How to run a restaurant

    As two newbies discovered, there's more to it than good food
    Record Store Day: Remembering an era when buying and selling discs were labours of love

    Record Store Day: The vinyl countdown

    For Lois Pryce, working in a record shop was a dream job - until the bean counters ruined it
    Usher, Mary J Blige and Will.i.am to give free concert as part of the Global Poverty Project

    Mary J Blige and Will.i.am to give free concert

    The concert in Washington is part of the Global Citizen project, which aims to encourage young people to donate to charity
    10 best tote bags

    Accessorise with a stylish shopper this spring: 10 best tote bags

    We find carriers with room for all your essentials (and a bit more)
    Paul Scholes column: I hear Manchester City are closing on Pep Guardiola for next summer – but I'd also love to see Jürgen Klopp managing in England

    Paul Scholes column

    I hear Manchester City are closing on Pep Guardiola for next summer – but I'd also love to see Jürgen Klopp managing in England
    Jessica Ennis-Hill: 'I just want to give it my best shot'

    Jessica Ennis-Hill: 'I just want to give it my best shot'

    The heptathlete has gone from the toast of the nation to being a sleep-deprived mum - but she’s ready to compete again. She just doesn't know how well she'll do...